论文信息 - First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population. - 字舞流文

First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population.

J. Reardon | L. Abushahin | Eric M McLaughlin | Terence Williams | Matthew J. Arango | A. Hatashima | Tracelyn Freeman | Terence M. Williams | Eric M. McLaughlin